文献速递临床试验与 GCP医学人工智能与信息学

一项随机对照试验的研究方案:评估含传感器鞋垫联合照片记录远程医疗对糖尿病足溃疡的预防效果

Study protocol for a randomized controlled trial to test for preventive effects of diabetic foot ulceration by telemedicine that includes sensor-equipped insoles combined with photo documentation.
PubMed 文献 · Trials · 2019-08-22

该试验为开放标签、前瞻性、为期24个月的随机对照试验,计划纳入300例18-85岁伴严重糖尿病周围神经病变(振动觉≤4/8)的1型或2型糖尿病患者,按1:1分配至对照组和干预组。干预组使用配备传感器的鞋垫及智能手机应用每日在家测量足部温度两次(间隔>4小时),当左右对应部位温差>1.5°C持续>32小时(警报级别4)时由医生启动干预阶段。主要结局为研究期间任何时间点由医生评估的足部溃疡。

要点

  • 干预组使用传感器鞋垫每日在家测量足温两次,间隔>4小时,持续24个月。
  • 左右对应部位温差>1.5°C持续>32小时(警报级别4)时,医生启动干预阶段。
  • 主要结局为研究期间任何时间点由医生评估的足部溃疡。

核心结论

  • 该研究方案旨在探讨借助智能传感器鞋垫联合照片记录进行每日居家足部温度测量对糖尿病足溃疡的预防效果。

研究设计与样本

  • 开放标签、前瞻性、随机对照试验,为期24个月,计划招募300例1型或2型糖尿病伴严重糖尿病周围神经病变(振动觉≤4/8)、年龄18-85岁的患者,按1:1分配至对照组和干预组。
  • 纳入标准包括按国际糖尿病足工作组(IWGDF)糖尿病足风险分类系统为风险组2或3,以及能够使用手机。

关键数值与推荐

  • 干预组患者使用插入传感器鞋垫的拖鞋及智能手机应用(Smart Prevent Diabetic Feet Application)。
  • 鞋垫记录足底温度变化,患者在整个24个月研究期间每日在家测量足温两次,间隔>4小时。
  • 当左右对应部位温差>1.5°C持续>32小时(警报级别4)时,医生启动干预阶段,要求患者减少日常活动并放松足部五天。
  • 干预期间鼓励患者进行照片记录,可能安排患者就诊私人医生或临床检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early detection of diabetic foot ulcerations (DFUs) can avoid or delay any progression into more severe stages, which may require limb amputation or lead to infectious sequelae and death. However, frequent clinical screening would be too intrusive and costly, and self-examination may be hampered by concomitant diseases and social disabilities. In addition, it requires professional knowledge and experience using specialized devices. Researchers reported that skin temperature monitoring could reduce the risk of DFUs in high-risk patients. The main research objects in this field are effective and convenient means of temperature measurement, accurate and reasonable early warning mechanisms, and timely and appropriate interventions. This trial aims to investigate the effectiveness of daily home-based foot temperature measurements in the prevention of DFUs with the aid of intelligent sensor-equipped insoles combined with photo documentation. METHODS/DESIGN: In this open-label, prospective, randomized, 24-month trial, 300 patients with diabetes mellitus (type 1 or 2) and severe diabetic peripheral neuropathy (vibration sensation ≤ 4/8), aged 18-85 years, will be recruited and assigned to control and intervention groups in a ratio of 1:1. Main inclusion criteria to be eligible for study participation encompass in particular risk group 2 or 3 for the development of DFUs using the diabetic foot risk classification system (as specified by the International Working Group on the Diabetic Feet [IWGDF]) and the ability to use a mobile phone. INTERVENTIONS: Participants in both groups will receive education about regular foot care at the beginning of the study (visit 0). In the intervention group, every patient will receive a pair of slippers with the inserted sensor-equipped insole as well as a smartphone with the corresponding smartphone application (Smart Prevent Diabetic Feet Application). The insole is a tool that records the temperature variabilities of the plantar foot. Patients will measure their foot temperature twice a day at home with a time interval > 4 h during the entire course of the study (24 months). The measured data will be initially analyzed and visualized, and further transferred to a remote server that allows the physician to perform specific interpretations. In case of temperature differences > 1.5 °C between left and right corresponding sites lasting > 32 h (assigned alarm level 4), the physician will start an intervention phase, which requires the patient to reduce daily activities and relax his feet for five days. At the same time, photo documentation is encouraged to be performed by the patient. Possibly, additional visits to a private doctor or clinical examinations will be arranged for the patient during this intervention period. OUTCOMES: The primary outcome is foot ulceration, evaluated by a physician, and occurring at any point during the study. DISCUSSION: This study addresses principal aspects in the prevention of DFUs. First, the sensor-equipped insole will be evaluated for daily performance in home-based measurements of foot temperatures. Second, a telemedicine structure is tested that evaluates sensor data automatically and proposes suitable intervention measures under the supervision of a physician. Third, predictive models for DFUs will be built using the collected sensor data allowing for interpretations, which in the future may support medical care providers. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), DRKS00013798 . Registered on 18 January 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ming A, Walter I, Alhajjar A, et al. Study protocol for a randomized controlled trial to test for preventive effects of diabetic foot ulceration by telemedicine that includes sensor-equipped insoles combined with photo documentation. Trials. 2019. PMID: 31439007. doi:10.1186/s13063-019-3623-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。